AI Infrastructure, Biologics Expansion, and Digital Platforms Drive Strategic Realignment
This morning’s tape is defined by strategic repositioning across healthcare, AI infrastructure, and digital platforms. From cross-border biologics ambitions to enterprise AI alliances and improving profitability profiles, companies are signaling where capital and execution are heading in 2026, with Totaligent (OTCID:TGNT) Expanding its Biologics and APAC Ambitions